Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.

By R. Fielding, B. Vellas, W. Evans, S. Bhasin, J. Morley, Anne B. Newman, G. Abellán van Kan, S. Andrieu, J. Bauer, D. Breuillé and 15 more. Journal of the American Medical Directors Association, 2011

3,007 citations recorded by the source corpus.

Subfields: Geriatrics and Gerontology, Physiology

View Paper: https://www.semanticscholar.org/paper/fab9241ffc79c129113ea37cdda1532fb490c6fa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Geriatrics and Gerontology

1. Luigi Ferrucci
2. J. Morley
3. Brian C. Clark
4. S. Anker
5. O. Theou
6. E. Dent

In Physiology

1. S. Larsson
2. Shuai Yuan
3. Luigi Ferrucci
4. Brian C. Clark
5. J. Morley
6. Stephen B. Kritchevsky
7. S. Anker

Citations in the corpus

• International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management (2018, positive): “The majority of the evidence behind this recommendation comes from the two background meta-analyses (4, 11), with support from all international workgroup statements regarding interventions for sarcopenia (3, 5, 11, 25, 26), as well as all task force members.”
• Sarcopenia and its association with falls and fractures in older adults: A systematic review and meta‐analysis (2019, result): “This highlights the importance of muscle strength or physical performance in the sarcopenia definition, in line with current definitions.(58,59,61,62,68,93) However, literatures also showed the value of including muscle mass in sarcopenia definitions.”
• Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. (2023, background): “There are also other definitions for sarcopenia, including the International Working Group on Sarcopenia (IWGS) [10] and the Foundation for the National Institute of Health (FNIH) [11].”
• Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies (2017, methodology): “The population- based studies that reported the prevalence of sarcopenia in healthy adults aged ≥ 60 years using the European Working Group on Sarcopenia in Older People (EWGSOP), the International Working Group on Sarcopenia (IWGS) and Asian Working Group for Sarcopenia (AWGS) definitions, were sel”
• Clinical definition of sarcopenia. (2014, methodology): “The consensus definitions were as follows: • The presence of low skeletal muscle mass and either low muscle strength (e.g., handgrip) or low muscle performance (e.g., walking speed or muscle power); when all three conditions are present, severe sarcopenia may be diagnosed (EWGSOP); • The presence of”